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Optical coherence tomography (OCT) is a noninvasive imaging modality providing high‑resolution images 
of the central retina that has completely transformed the field of ophthalmology. While traditional OCT has 
produced longitudinal cross‑sectional images, advancements in data processing have led to the development 
of en‑face OCT, which produces transverse images of retinal and choroidal layers at any specified depth. 
This offers additional benefit on top of longitudinal cross‑sections because it provides an extensive overview 
of pathological structures in a single image. The aim of this review was to discuss the utility of en‑face OCT 
in the diagnosis and management of age‑related macular degeneration (AMD) and polypoidal choroidal 
vasculopathy (PCV). En‑face imaging of the inner segment/outer segment junction of retinal photoreceptors 
has been shown to be a useful indicator of visual acuity and a predictor of the extent of progression 
of geographic atrophy. En‑face OCT has also enabled high‑resolution analysis and quantification of 
pathological structures such as reticular pseudodrusen (RPD) and choroidal neovascularization, which 
have the potential to become useful markers for disease monitoring. En‑face Doppler OCT enables subtle 
changes in the choroidal vasculature to be detected in eyes with RPD and AMD, which has significantly 
advanced our understanding of their pathogenesis. En‑face Doppler OCT has also been shown to be useful 
for detecting the polypoid lesions and branching vascular networks diagnostic of PCV. It may therefore 
serve as a noninvasive alternative to fluorescein and indocyanine green angiography for the diagnosis of 
PCV and other forms of the exudative macular disease.
Key words: Age‑related macular degeneration, en‑face optical coherence tomography, polypoidal choroidal 
vasculopathy
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Optical coherence tomography (OCT) is a noninvasive imaging 
modality providing high‑resolution images of the central retina 
and optic nerve head that has completely transformed the 
field of ophthalmology. Utilizing light waves emitted from a 
broadband infra‑red light source, it detects light reflected from 
the retina at various depths to create cross‑sectional images 
of the retina.
Time‑domain OCT (TD‑OCT) was the first technique 
employed, using a moving reference mirror to collect 
back‑scattered light from the retina. TD‑OCT had the ability 
to obtain images at a rate of 400 A‑scans per second and a 
resolution of 8–10 µm.[1]
The development of spectral‑domain OCT (SD‑OCT), which 
utilized an interferometer and high speed spectrometer to 
simultaneously detect light of different frequencies, without the 
need for a moving reference mirror, allowed faster acquisition 
of images of up to 20,000–52,000 A‑scans per second, as well 
as higher resolution of 5–7 µm.[1]
Conventional OCT methods were unable to visualize the 
choroid well due to scattering of light by the retinal pigment 
epithelium (RPE). Nevertheless, new techniques have been 
developed with the aim of improving visualization of the 
choroid. Examples include image averaging and enhanced 
depth imaging (EDI). Image averaging obtains the average of 
multiple B‑scans of the retina at a given location, to increase the 
signal‑to‑noise ratio. EDI‑OCT utilizes the sensitivity roll‑off 
phenomenon of SD‑OCT and places the choroid‑sclera interface 
at the zero line, to enhance visualization of the choroid.
Ultra high‑resolution OCT (UHR‑OCT) and swept source 
OCT (SS‑OCT) are newer prototype systems. UHR‑OCT uses 
broadband light sources to achieve a resolution of 3 µm. 
SS‑OCT is a variation of SD‑OCT, in which the swept laser 
light source sequentially emits light of varying frequencies, 
of which the reflections are detected by photodetectors rather 
than a spectrometer. SS‑OCT uses light with a wavelength 
of 1060 nm that increases depth penetration, thus improving 
visualization of the choroid. SS‑OCT has acquisition rates of 
up to 100,000–236,000 A‑scans per second and a resolution of 
up to 11 µm.[2]
Doppler OCT is a technique that utilizes ultra‑high‑speed 
image acquisition with SD‑OCT, using blood flow as a contrast 
medium, to evaluate retinal and choroidal vasculature with 
precise depth resolution.
Advancements in software and data processing have led 
to the development of en‑face OCT. En‑face imaging is an 
emerging technique that combines SD‑OCT with transverse 
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confocal analysis, producing transverse images of retinal 
and choroidal layers at a specified depth. In other words, 
it provides an en‑face view of any given layer within the 
retina and choroid. En‑face imaging offers many additional 
advantages over conventional longitudinal cross‑sections 
because it can delineate microstructural and morphological 
changes in coronal view, allows precise measurements to be 
made, and provides a more extensive overview of pathological 
structures in a single image. It also provides a familiar view 
of the fundus similar to that seen on fundus photography and 
direct ophthalmoscopy.
Nevertheless, there are some drawbacks of OCT 
compared with other imaging modalities such as fluorescein 
angiography (FA), indocyanine green (ICG), angiography and 
fundus autofluorescence (FAF). FA and ICG are both dynamic 
studies that can demonstrate leakage of dye from abnormal 
blood vessels and pooling of dye within pigment epithelial 
detachments (PEDs) or neurosensory retinal detachments. 
This is in contrast to OCT, which is static and does not give 
direct information about the integrity of the vasculature. 
Furthermore, the difficulty in differentiating between various 
causes of PEDs based on their morphology on en‑face OCT 
makes it less specific than FA for the diagnosis of exudative 
age‑related macular degeneration (AMD). Similarly, ICG 
studies the choroidal circulation and is more specific than OCT 
for the diagnosis of polypoidal choroidal vasculopathy (PCV) 
and retinal angiomatous proliferation, as it can demonstrate the 
polyps and branching vascular networks in PCV[3] as well as the 
retinal‑retinal anastomoses and retinal‑choroidal anastomoses 
in retinal angiomatous proliferation.[4] FAF is useful in 
monitoring the progression of geographic atrophy (GA) 
because it gives information concerning the metabolic activity 
of the RPE cells, something, which cannot be demonstrated by 
en‑face OCT.
The aim of this review was to discuss the utility of en‑face 
OCT in the diagnosis and management of AMD and PCV.
Methods
A literature search was performed using the PubMed database 
up to October 2014. Keywords including “en‑face,” “OCT,” 
“AMD,” “PCV,” “retinal angiomatous proliferation,” and 
“RAP” were used in various combinations. Articles are 
reporting the use of en‑face OCT for in AMD, PCV, and RAP 
were reviewed. A search through the references of the retrieved 
articles was also performed. This review included all the 
clinical studies published. Only articles published in English 
were included.
Age‑Related Macular Degeneration
Good correlation with other imaging modalities
Superimposing fluorescein angiography images with en‑face optical 
coherence tomography images
As early as 2005, van Velthoven et al. demonstrated the value 
of overlaying fluorescein angiograms onto en‑face OCT images 
in retinal disease. By combining functional and structural 
information into one image, zones of vascular leakage could 
be correlated with changes in the retina and RPE. In a case 
of retinal angiomatous proliferation, the overlay image 
demonstrated the potential for en‑face OCT to reveal the extent 
of retinal PED where fluorescein leakage was blocked.[5]
Correlating pathological features in dry and wet age‑related macular 
degeneration with other imaging modalities
A pilot study on en‑face OCT in AMD was done in 2008. 
A total of 7 eyes with dry AMD and 5 eyes with wet AMD 
were studied, and en‑face SD‑OCT images were superimposed 
onto conventional imaging modalities for correlation 
of pathological features such as drusen, GA, choroidal 
neovascularization (CNV), macular edema, and subretinal 
fluid. Findings were promising: In wet AMD patients, the 
location and extent of CNV, macular edema, and subretinal 
fluid were visualized on en‑face OCT and in some cases even 
identified in areas not seen with conventional imaging. In dry 
AMD patients, the location of drusen and GA corresponded 
to autofluorescence. In 4 of 12 eyes, en‑face OCT identified 
subretinal fluid, which was not seen on FA.[6]
Simultaneous functional and structural imaging with combined 
optical coherence tomography/indocyanine green angiography
Rosen et al. studied 30 eyes with macular disease, the 
majority of which had neovascular AMD, and performed 
simultaneous imaging with OCT, confocal scanning laser 
ophthalmoscopy (SLO), and ICG. A mixer channel was used 
to superimpose information from the en‑face OCT and the 
ICG into a single transverse image. They demonstrated how 
simultaneous OCT/ICG imaging allowed better correlation 
between structural and functional abnormalities. The two 
imaging modalities complemented each other, with OCT 
providing greater depth resolution, allowing identification of 
occult neovascularization in areas not well visualized on ICG, 
such as beneath regions of scarring and PEDs.[7]
Imaging of the inner segment/outer segment junction
Imaging of photoreceptor integrity
The brightness or intensity of the inner segment/outer 
segment (IS/OS) junction on OCT was found by Hayashi et al. 
to be correlated with visual acuity in retinal diseases including 
AMD.[8] Wanek et al. used en‑face SD‑OCT imaging of the IS/OS 
junction to visualize the integrity of the photoreceptor cells in 
various retinal diseases.[9] In a patient with neovascular AMD, 
en‑face OCT of the IS/OS junction showed nonuniform intensity 
levels and focal areas of higher intensities, corresponding 
to topographic variations in the inner and OSs as a result of 
the underlying drusen deposition. En‑face OCT of the IS/OS 
junction revealed focal areas of reduced intensity in patients 
with other retinal disease including macular hole, central serous 
retinopathy, cystoid macular edema and diabetic retinopathy, 
clearly delineating the areas of pathology. Fig. 1 is an example 
of en‑face OCT scan delineating a localized area of damaged 
photoreceptor IS/OS junction. En‑face imaging may be a 
useful tool for monitoring the integrity of photoreceptor cells 
in retinal disease.
Correlation of inner segment/outer segment junction areas with 
visual acuity
Kiernan et al. used en‑face OCT to calculate the area of intact 
IS/OS junction in the outer retinal photoreceptor layer. Totally, 
74 eyes were examined, of which 30 were healthy, 19 had 
intermediate to advanced dry AMD, and the rest had other 
retinal pathology. They found that there was a significant 
correlation between central en‑face IS/OS junction area and 
visual acuity in all eyes except those with dry AMD. The 
correlation was greater than that shown between visual acuity 
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and central subfield thickness, macular volume, and average 
macular thickness. However, there was poor correlation 
between IS/OS junction area and visual acuity in patients 
with dry AMD. This may be explained by the disruption of 
the IS/OS and RPE planes on en‑face sections due to drusen, 
RPE changes and PEDs, causing loss of the hyper‑reflective 
band at the IS/OS junction.[10]
Predicting the progression of geographic atrophy
Holz et al. demonstrated the utility of en‑face OCT in 
predicting the area of progression of GA in dry AMD. Similar 
to the hyperautofluorescent border of progressing GA in FAF 
imaging,[11] en‑face OCT of the IS/OS junction showed a dark 
area extending beyond the borders of GA that accurately 
predicted the extent of progression of GA over the following 
year in 13 of 30 eyes. In other words, en‑face OCT can identify 
the area of IS/OS disruption corresponding to the area of 
photoreceptor loss, which is at high risk of progression of GA.[12]
Imaging of the outer retina
Characterization of outer retinal tubulations
Outer retinal tubulations (ORTs) are lesions located in the outer 
nuclear layer, often overlying areas of subretinal fibrosis or 
pigment epithelial alterations in both neovascular and atrophic 
AMD. Wolff et al. used en‑face SD‑OCT to differentiate between 
ORTs. They found that ORTs in neovascular AMD formed 
a branching “pseudo‑dendritic” pattern emanating from a 
fibrovascular (FV) scar. On the other hand, ORTs in atrophic 
AMD followed a circular pattern with invaginations around 
the periphery of the atrophic zone.[13]
Imaging of the subretinal space, retinal pigment epithelium, 
pigment epithelial detachments, drusen, and choroidal 
neovascularization
Visualization of sub‑retinal pigment epithelium changes in 
exudative age‑related macular degeneration ‑ detection of occult 
choroidal neovascularization
De Bruin et al. were the first to show that ultra‑high‑speed 
SS‑OCT using a wavelength of 1050 nm provided a better 
penetration below the RPE compared with conventional 
SD‑OCT at 850 nm. En‑face images were reconstructed from 
120 cross‑sections. In patients with exudative AMD, the 
en‑face reconstructions were able to detect areas of reduced 
reflectivity between the RPE and Bruch’s membrane, which 
correlated well with areas of type 1 CNV on FA. After treatment 
with ranibizumab, this area showed a marked reduction in 
size. However, the authors acknowledged the difficulty in 
differentiating between CNV and sub‑RPE fluid.[14]
Characterization of pigment epithelial detachments
En‑face OCT was used to compare the morphology of PED 
in 9 eyes with central serous chorioretinopathy (CSC) and 
21 eyes with neovascular AMD. In CSC, PEDs were frequently 
circular in shape, had a smooth inner silhouette, contained 
clear content, and had a uniform or slightly irregular wall 
aspect. In neovascular AMD, PEDs were often irregular or 
multilobular in shape had a granular inner silhouette, and an 
irregular wall aspect. PED wall thickness and dimensions were 
larger in AMD compared with CSC. The authors suggested that 
en‑face sections were able to provide additional information 
to conventional longitudinal sections, as they gave a better 
overview of the area of PED and allowed more accurate 
measurements of PED wall thickness and shape. En‑face OCT 
may, therefore, be useful in distinguishing between PEDs in 
CSC and AMD.[15]
Detection of intraretinal retinal pigment epithelium migration in dry 
age‑related macular degeneration
Intra‑retinal RPE migration can be detected on en‑face OCT as 
small discrete hyper‑reflective, highly‑back‑scattering lesions 
within the neurosensory retina. In a study of 55 eyes with 
early to intermediate dry AMD, en‑face OCT demonstrated 
intra‑retinal RPE migration in 54.5%. In all of these eyes, the 
areas of intraretinal RPE migration corresponded to RPE 
pigment clumping on fundus photographs. RPE pigment 
migration was seen most frequently in the outer nuclear layer 
and occurred above areas of drusen in 74%. This suggests that 
drusen may play a role in the stimulation of intraretinal RPE 
migration.[16]
Visualization of choroidal neovascularization within fibrovascular 
pigment epithelial detachment ‑ a potential alternative to indocyanine 
green angiography
En‑face imaging can also visualize CNV in FV‑PEDs due to 
exudative AMD. Coscas et al. showed that en‑face EDI SD‑OCT 
was able to demonstrate the CNV as a hyper‑reflective network 
within the FV‑PED in 30 out of 38 eyes with AMD, with an 
underlying area of homogeneous hypo‑reflectivity consistent 
with serous exudation. The course of the hyper‑reflectivity on 
OCT corresponded well with the hyper‑fluorescent network 
on ICG. In the other 8 eyes, en‑face imaging showed dense, 
homogenous hyper‑reflectivity within the FV‑PED, suggestive 
of fibrous tissue obscuring the CNV. Fig. 2 is an en‑face OCT 
scan revealing the total extent of occult CNV. With the ability 
to detect CNV on en‑face OCT, it may be possible in future 
to diagnose type 1 exudative AMD noninvasively, without 
the need for FA and ICG, both of which require intravenous 
contrast injection.[17]
Quantitative drusen measurements – potential biomarkers for 
age‑related macular degeneration progression
Quantitative drusen measurements calculated from en‑face 
projection images of the RPE layer could be used to monitor 
the progression of dry AMD. Chen et al. developed a novel 
Figure 1: En‑face image at the level of inner segment/outer segment 
junction (IS/OS) showing IS/OS junction damaged area (yellow 
boundary)
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algorithm for automated drusen segmentation using SD‑OCT. 
By superimposing the observed and expected RPE contours, the 
differences in between the two layers can be marked as drusen. 
An en‑face projection image of the drusen and RPE layer is 
then generated, which not only helps eliminate false positive 
drusen, but also provides a useful method of visualization of 
drusen, and enables the computation of potential biomarkers 
such as drusen area and shape, which could be used to monitor 
progression of dry AMD.[18]
Microstructure of reticular pseudodrusen
Subretinal  drusenoid deposits  (SDD) or ret icular 
pseudodrusen (RPD) is a lesion found in AMD that is 
highly associated with progression to CNV, GA, and 
outer retinal atrophy. Meadway et al. used adaptive 
optics (AO)‑SLO, correlated with AO‑OCT to analyze the 
en‑face microstructure of SDD. On AO‑SLO areas of SDD 
appeared as a hypo‑reflective annulus surrounding a 
reflective core of regularly spaced hyper‑reflective dots in a 
mosaic pattern. It was uncertain whether the reflective core 
was attributed to changes in the overlying photoreceptors. 
When correlated with en‑face AO‑OCT, the authors concluded 
that the reflective core represented SDD material itself, 
rather than the overlying photoreceptors. AO‑OCT also 
revealed that the SDD consisting of discrete hyper‑reflective 
granules were deposited above the RPE and encroached upon 
the IS/OS junction with little effect on layers of retina above 
the external limiting membrane.[19]
Imaging of the choroidal vasculature
Correlation of reticular pseudodrusen with choroidal stroma
En‑face OCT sections of the choroid demonstrated the close 
relationship between RPD and the intervascular choroidal 
stroma. Sohrab et al. examined 97 eyes with dry AMD, who 
had RPD. Point‑to‑point comparison of infrared reflectance, 
autofluorescence, and red‑free images with en‑face OCT 
sections of the choroid revealed that the RPD lesions aligned 
with the choroidal stroma in areas between choroidal vessels. 
The RPD closely abutted and often aligned along the course 
of the large choroidal vessels. Interestingly, disruptions of the 
IS/OS junction was found immediately adjacent to the RPD 
lesions rather than overlying them. This suggests that RPD may 
be associated with inflammatory or atrophic changes in the 
intervascular choroidal stroma, whereas the IS/OS disruptions 
may be secondary changes induced by the RPD.[20]
Quantification of choroidal vasculature
To further elucidate the role of choroidal vessels in the 
pathogenesis of AMD and RPD, Sohrab et al. performed a 
case–control study of patients with early dry AMD and RPD, 
in which en‑face volumetric SD‑OCT was used to quantify 
choroidal vascular density, vessel size, and choroidal thickness. 
Choroidal vascular density was defined as the area occupied 
by choroidal vessels, expressed as a percentage of the total area 
of choroid visualized on a 6 mm × 6 mm en‑face image. The 
patients were divided into three groups: Controls (14 patients), 
early AMD (11 patients), and RPD (33 patients). Eyes that fit the 
criteria for both early AMD and RPD were excluded. En‑face 
OCT choroidal sections showed that the choriocapillaris was 
absent in 100% of RPD patients, 55% of early AMD patients and 
0% of controls. Choroidal vascular density was lowest in early 
AMD and highest in RPD patients. Although RPD patients had 
a complete loss of choriocapillaris, choroidal vascular density 
remained the highest because of the presence of larger choroidal 
vessels. Choroidal vessel diameter was comparable among the 
three groups, as was the choroidal thickness. These findings 
suggest a role for larger choroidal vessels in the pathogenesis 
of RPD. They are also consistent with the histopathology of 
choriocapillaris atrophy and vascular dropout in dry AMD.[21]
Imaging of the choriocapillaris– potential to detect early, subtle 
choroidal vascular abnormalities in geographic atrophy
Kim et al. developed phase‑variance OCT (pvOCT), which uses 
the motion observed over time to calculate contrast and produce 
capillary perfusion maps of the retina and en‑face images of 
vasculature in different layers of the retina and choroid. 
These layers include the choriocapillaris underneath Bruch’s 
membrane, Sattler’s layer containing medium‑sized choroidal 
vessels, and Haller’s layer containing large choroidal vessels 
and pigmented cells. En‑face pvOCT of a patient with GA 
due to dry AMD revealed small focal areas of choriocapillaris 
dropout within the region of GA. Such early morphological 
changes in the choriocapillaris in GA are poorly visualized 
on fundal examination and other imaging modalities, such 
as autofluorescence, FA, and ICG. Therefore, en‑face pvOCT, 
with its ability to provide high‑resolution, depth‑resolved 
microvascular imaging, particularly of the anterior choroidal 
vasculature, and choriocapillaris has the potential to detect 
subtle choroidal vascular abnormalities and permit the early 
diagnosis of GA. Moreover, pvOCT is not affected by regional 
vascular leakage, unlike contrast imaging modalities. Another 
advantage of pvOCT is that it can be integrated into existing 
OCT systems by means of software, without requiring any 
hardware modifications.[22]
Investigation of abnormal choroidal vasculature in exudative macular 
disease
Hong et  al .  developed Doppler optical  coherence 
angiography (OCA) to investigate choroidal vasculature in 
patients with myopic CNV, AMD, and PCV. SS‑OCT using 
1050 nm wavelength of light for high penetration (HP) 
was modified to measure chorioretinal blood flow, and 
Figure 2: Spectral domain optical coherence tomography B‑scan 
showing a type 1 membrane in an eye with occult choroidal 
neovascularization (top image‑arrow). En‑face image (bottom image) 
at the level of retinal pigment epithelium showing the total extent of 
the occult membrane (arrowheads)
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en‑face angiogram images were reconstructed. En‑face 
angiograms showed pathological choroidal vessels as areas 
of hyper‑scattering, whereas choroidal vessels in normal 
eyes showed hypo‑scattering. Bidirectional OCA visualized 
choroidal feeder vessels close to the PED in 3 of 5 eyes with PCV, 
which correlated with feeder vessels appearing in the early 
phase of ICG. High‑sensitive OCA visualized the morphology 
of the branching vascular networks and polyps in eyes with 
PCV. There was a high correlation between high‑sensitive 
OCA en‑face angiograms and the mid‑phase of ICG. With the 
ability to provide noninvasive three‑dimensional choroidal 
vascular imaging with good correlation with ICG, en‑face OCA 
may in future be an alternative to FFA and ICG for imaging of 
exudative macular disease.[23]
Quantifying choroidal neovascularization flow
Structural OCT cannot identify CNV because of its similar 
reflectivity to drusen and hemorrhage. Therefore, a 
flow‑imaging OCT technology is needed to visualize CNV. 
Jia et al. used SS‑OCT angiography to identify and quantify 
CNV flow. En‑face projections of three distinct vascular layers 
were generated: Inner retina (showing retinal vasculature), 
outer retina (showing CNV), and choroid. CNV area and flow 
were also calculated from the en‑face angiograms. Results 
were promising, with the en‑face composite images combining 
angiographic information (CNV size, location, and flow index) 
with structural information (sub‑retinal fluid and intraretinal 
cysts). In patients with neovascular AMD, OCT angiograms 
of the choroidal layer showed patchy loss of choriocapillaris, 
which led to the exposure of the underlying large, deep 
choroidal vessels, which were not visualized in normal controls. 
They also showed focal areas of decreased choroidal flow and 
loss of deeper choroidal vessels adjacent to the CNV, which may 
play a role in the pathogenesis of CNV. The en‑face angiograms 
were also able to show vascular patterns, which were obscured 
by subretinal hemorrhage on FA.[24]
Calculation of choroidal vascular area
Ueda‑Arakawa et al. used en‑face HP SS‑OCT to evaluate the 
choroidal vasculature in patients with RPD, of which some 
had early AMD, some had GA, and some had neovascular 
AMD. The en‑face image at the level mid‑way between Bruch’s 
membrane and the chorioscleral interface was used to calculate 
the area of the choroidal vasculature. The choroidal vascular 
area was significantly lower in eyes with RPD compared to 
controls. En‑face images showed narrow and sparse choroidal 
vessels in eyes with RPD.[25]
Polypoidal Choroidal Vasculopathy
Detection of branching vascular networks and polypoidal 
lesions using en‑face optical coherence tomography ‑ 
ophthalmoscopy
As early as 2007, Kameda demonstrated the utility of en‑face 
OCT as a screening examination for PCV. Totally, 57 eyes with 
PCV were examined with en‑face OCT at sequential depths, 
which identified polypoidal lesions in 84% and branching 
vascular networks in 53%. Polypoidal lesions appeared as 
characteristic small and round protrusions of the RPE, whereas 
branching vascular networks appeared as slight elevations 
of the RPE. Based on the RPE abnormalities detected on the 
en‑face sections, further longitudinal scans could be performed 
to characterize further the lesions.[26]
Features of polypoidal lesions on en‑face optical coherence 
tomography ‑ ophthalmoscopy
Saito further characterized features of PCV using 
OCT‑ophthalmoscope, which combined en‑face OCT with SLO. 
A total of 50 eyes with PCV were examined. In each of the 22 eyes 
with serous or hemorrhagic PED, en‑face images demonstrated 
the polypoidal lesions as irregularities or protrusions in the 
reflective line corresponding to the PED. In the remaining, 28 eyes 
without a PED, the polypoidal lesions appeared on en‑face 
images as distinctive bright rings of a highly reflective RPE 
line in 26 of 28 eyes. Branching vascular network was revealed 
as a highly reflective geographic area on en‑face imaging in 
32 of 41 eyes. En‑face OCT‑ophthalmoscopy imaging can detect 
polypoidal lesions and branching vascular networks, which may 
be useful for noninvasive diagnostic imaging of PCV.[27]
Visualization of polypoidal lesions and dilated choroidal 
vascular networks on high penetration‑optical coherence 
tomography
In a study of 19 eyes with PCV, HP SS OCT using 1060 nm 
wavelength for better penetration of the choroidal layer 
was able to detect polypoidal lesions and dilated choroidal 
vascular networks. En‑face HP‑OCT images showed 41 of 
47 of the polypoidal lesions seen on ICG, appearing as RPE 
rings with inner reflectivity, with hyporeflective dots, which 
were presumed to be the sites at which the polyps entered 
Bruch’s membrane. In addition, six polypoidal lesions 
detected on en‑face HP‑OCT were not visualized on ICG, 
which was postulated to be due to reduction in blood flow in 
polypoidal lesions after treatment with intravitreal injection of 
an anti‑vascular endothelial growth factor and/or verteporfin 
photodynamic therapy. En‑face HP‑OCT images showed 
dilated choroidal vessels beneath 47% of the polypoidal lesions 
compared with 33% on ICG. The branching choroidal vascular 
network was visualized on HP‑OCT as tortuous lines within 
hyper‑reflective mesh‑like configuration in 79% of eyes. The 
advantage of using en‑face OCT in screening for PCV lies in 
its ability to view the extent of the entire lesion in a single 
image in a noninvasive manner.[28] Fig. 3 shows an en‑face 
OCT image revealing a hyperreflective area of elevated RPE 
Figure 3: En‑face image (right panel) of an eye with polypoidal 
choroidal vasculopathy showing abnormal vascular network just below 
the level of retinal pigment epithelium as shown on cross‑sectional 
scan (left panel)
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by the underlying branching vascular network, with abnormal 
choroidal vessels appearing as hyporeflective lines in‑between.
Conclusion
En‑face OCT has opened up a whole spectrum of imaging 
capabilities for the diagnosis and management of the 
exudative macular disease. This review identified a number 
of publications that described the utility of en‑face OCT in the 
management of AMD and PCV.
En‑face OCT allows noninvasive, depth‑resolved imaging of 
any layer within the retina and the choroid, without the need 
for intravenous contrast injection. Potential applications of 
en‑face OCT include prediction of the extent of progression of 
GA and quantification of pathological structures such as RPD 
and CNV for disease monitoring.
Finally, the development of en‑face Doppler OCT has 
demonstrated subtle changes in the choroidal vasculature in 
AMD, which has significantly advanced our understanding 
of its pathogenesis. En‑face Doppler OCT can also detect the 
polypoidal lesions and branching vascular networks diagnostic 
of PCV. It may, therefore, give additional information for the 
diagnosis of PCV and other forms of exudative macular disease 
on top of those revealed by fluorescein and ICG.
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